Search results
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoThe firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA ...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 6 days agoThe stock was down 5.5% Wednesday morning, bringing the stocks losses to 13% since the market closed...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Colorado Springs Gazette· 6 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 2 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 1 day agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
Bloomberg· 4 days agoModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 12 hours agoThe Stock Advisor service has more than quadrupled the return...Motley Fool has positions in and...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 7 days agoThe three vaccines updated to target the SARS-CoV-2 XBB.1.5 subvariant -- Moderna's and Pfizer-BioNTech's mRNA vaccines</ ...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 5 days agoThe authors said the findings underscore the need for new boosters. Next week, the Center for...
The chicken and egg problem of fighting another flu pandemic
The State· 14 hours ago"It's almost comical to be using a 1940s technology for a 21st-century pandemic," said Rick Bright, who led the Health and Human Services Department's Biomedical Advanced Research and Development ...